Company Filing History:
Years Active: 2017-2018
Title: Daniel Anton De Boer: Innovator in Gene Therapy
Introduction
Daniel Anton De Boer is a notable inventor based in Putten, Netherlands. He has made significant contributions to the field of gene therapy, focusing on innovative methods to enhance the activity of specific proteins. With a total of 2 patents to his name, his work is paving the way for advancements in medical treatments.
Latest Patents
One of his latest patents is titled "Method for increasing the activity of a cystic fibrosis transmembrane conductance regulator protein." This invention relates to the field of gene therapy, specifically targeting oligonucleotides that can modify the sequence of a target RNA molecule present in living cells. Another patent, which shares a similar focus, also addresses oligonucleotides for making changes in RNA sequences within living cells. These patents highlight his commitment to improving therapeutic strategies for genetic disorders.
Career Highlights
Daniel is currently associated with Proqr Therapeutics II B.V., where he continues to develop innovative solutions in gene therapy. His work is instrumental in advancing the understanding and treatment of genetic conditions, particularly cystic fibrosis.
Collaborations
Daniel collaborates with Tita Ritsema, contributing to the innovative environment at Proqr Therapeutics II B.V. Their partnership exemplifies the collaborative spirit necessary for breakthroughs in the complex field of gene therapy.
Conclusion
Daniel Anton De Boer is a prominent figure in the realm of gene therapy, with a focus on enhancing protein activity through innovative oligonucleotide technologies. His contributions are vital for the future of genetic medicine.